Chronic Liver Diseases Therapeutics Market Report 2026
Download Free Sample Buy Now
Chronic Liver Diseases Therapeutics Market Global Report 2026 Market Report Infographic Image

Published : April 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Chronic Liver Diseases Therapeutics Market Report 2026

Global Outlook – By Treatment Type (Antiviral Drugs, Immunosuppressants Vaccines, Immunoglobulins, Corticosteroids, Targeted Therapy, Chemotherapy), By Disease Type (Hepatitis, Autoimmune Diseases, Non-Alcoholic Fatty Liver Disease, Cancer, Genetic Disorders), By Application (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Chronic Liver Diseases Therapeutics Market Overview

• Chronic Liver Diseases Therapeutics market size has reached to $15.88 billion in 2025

• Expected to grow to $25.99 billion in 2030 at a compound annual growth rate (CAGR) of 10.3%

• Growth Driver: Market Growth Driven By Increased Alcohol Use And Liver Health Challenges

• Market Trend: Advancements In Autologous Macrophage–Based Therapeutic Innovations

• North America was the largest region in 2025.

What Is Covered Under Chronic Liver Diseases Therapeutics Market?

Chronic liver disease therapeutics refers to the medical treatments and interventions aimed at managing long-term liver conditions. These therapies focus on slowing disease progression, alleviating symptoms, and improving liver function through medications, lifestyle changes, and, in some cases, advanced procedures.

The main treatment types of chronic liver diseases therapeutics are antiviral drugs, immunosuppressants, vaccines, immunoglobulins, corticosteroids, targeted therapy, and chemotherapy. Antiviral drugs are medications designed to prevent the replication of viruses in the body, helping to treat and manage viral infections. These treatments address various disease types, including hepatitis, autoimmune diseases, non-alcoholic fatty liver disease, cancer, and genetic disorders. It is distributed through various applications such as hospital pharmacies, retail pharmacies, and online pharmacies.

Chronic Liver Diseases Therapeutics Market Global Report 2026 Market Report bar graph

What Is The Chronic Liver Diseases Therapeutics Market Size and Share 2026?

The chronic liver diseases therapeutics market size has grown rapidly in recent years. It will grow from $15.88 billion in 2025 to $17.56 billion in 2026 at a compound annual growth rate (CAGR) of 10.6%. The growth in the historic period can be attributed to improved diagnosis of chronic liver conditions, expansion of antiviral therapy usage, increased management of autoimmune liver diseases, wider access to hospital-based liver care, growth of specialty hepatology services.

What Is The Chronic Liver Diseases Therapeutics Market Growth Forecast?

The chronic liver diseases therapeutics market size is expected to see rapid growth in the next few years. It will grow to $25.99 billion in 2030 at a compound annual growth rate (CAGR) of 10.3%. The growth in the forecast period can be attributed to increasing investments in NASH and fibrosis therapies, rising demand for precision liver medicine, expansion of biologic and targeted treatments, growing focus on early intervention strategies, increased clinical trial activity in liver diseases. Major trends in the forecast period include increasing development of targeted liver therapies, rising focus on disease-specific treatment approaches, growing adoption of combination drug regimens, expansion of non-invasive disease monitoring, enhanced emphasis on slowing disease progression.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Chronic Liver Diseases Therapeutics Market Segmentation

1) By Treatment Type: Antiviral Drugs, Immunosuppressants Vaccines, Immunoglobulins, Corticosteroids, Targeted Therapy, Chemotherapy

2) By Disease Type: Hepatitis, Autoimmune Diseases, Non-Alcoholic Fatty Liver Disease, Cancer, Genetic Disorders

3) By Application: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Antiviral Drugs: Nucleoside Or Nucleotide Analogues, Interferons, Direct-Acting Antivirals

2) By Immunosuppressants Vaccines: Calcineurin Inhibitors, mTOR Inhibitors, Purine Synthesis Inhibitors

3) By Immunoglobulins: Hepatitis B Immune Globulin, Intravenous Immunoglobulin

4) By Corticosteroids: Prednisolone, Methylprednisolone, Dexamethasone

5) By Targeted Therapy: Tyrosine Kinase Inhibitors, Monoclonal Antibodies

6) By Chemotherapy: Systemic Chemotherapy, Transarterial Chemoembolization Agents

What Is The Driver Of The Chronic Liver Diseases Therapeutics Market?

Increasing alcohol consumption is expected to propel the growth of the chronic liver disease therapeutics market going forward. Alcohol consumption is the intake of beverages containing ethanol, ranging from moderate to excessive use, with potential health impacts. Increasing alcohol consumption is due to growing social acceptance, rising incomes, and greater accessibility worldwide. Chronic liver disease therapeutics help manage liver damage caused by excessive alcohol consumption, slowing disease progression and improving liver function. For instance, in June 2024, according to the First Citizens Bank, a US financial institution, there was a 1.2% increase in direct-to-consumer (DTC) wine case sales in 2023 compared to 2022. Additionally, in December 2023, according to the report published by Kirin Holdings Company Limited, a Japan-based beverage company, it was noted that around 192.1 million kiloliters of beer were consumed in 2022, reflecting a 2.9% increase from the previous year. Therefore, the increasing alcohol consumption is driving the growth of the chronic liver disease therapeutics market.

Key Players In The Global Chronic Liver Diseases Therapeutics Market

Major companies operating in the chronic liver diseases therapeutics market are F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Bristol-Myers Squibb Company, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences Inc., Novo Nordisk A/S, Dr. Reddy's Laboratories Ltd., Vir Biotechnology Inc., Alnylam Pharmaceuticals Inc., Indian Immunologicals Limited, Intercept Pharmaceuticals Inc., Viking Therapeutics Inc., Ascletis Pharma Inc., Ochre Bio Limited, Tiziana Life Sciences Ltd., Antios Therapeutics Inc.

Global Chronic Liver Diseases Therapeutics Market Trends and Insights

Major companies operating in the chronic liver disease therapeutics market are focusing on developing innovative solutions such as engineered autologous macrophage cell therapy to enhance liver regeneration, reduce fibrosis progression, and provide more targeted, disease-modifying treatment options. Engineered autologous macrophage cell therapy refers to a treatment approach that uses a patient’s own macrophages, which are genetically modified or functionally enhanced outside the body, and then reinfused to reduce liver inflammation, promote tissue repair, and slow or reverse fibrosis in chronic liver diseases. For instance, in June 2024, Resolution Therapeutics Ltd., a UK-based biotechnology company, received approval from the UK Medicines and Healthcare Products Regulatory Agency (MHRA) to commence its Phase I/II EMERALD study for the lead candidate RTX001, targeting decompensated liver cirrhosis.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Chronic Liver Diseases Therapeutics Market?

In March 2024, Gilead Sciences Inc., a US-based pharmaceutical company, acquired CymaBay Therapeutics Inc. for approximately $4.3 billion. With this acquisition, Gilead Sciences aims to expand its portfolio in liver diseases, particularly focusing on non-alcoholic steatohepatitis (NASH) and other chronic liver conditions. CymaBay Therapeutics Inc. is a US-based company that focuses on developing therapies for liver diseases, including chronic liver conditions.

Regional Outlook

North America was the largest region in the chronic liver diseases therapeutics market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Chronic Liver Diseases Therapeutics Market?

The chronic liver disease therapeutics market includes revenues earned by entities by providing services such as genetic and molecular testing, liver transplantation, enzyme inhibitors, regular monitoring, and palliative and symptomatic care and related products, including pharmacological treatments, drugs, and emerging therapies. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Chronic Liver Diseases Therapeutics Market Report 2026?

The chronic liver diseases therapeutics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the chronic liver diseases therapeutics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Chronic Liver Diseases Therapeutics Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $17.56 billion
Revenue Forecast In 2035 $25.99 billion
Growth Rate CAGR of 10.6% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Treatment Type, Disease Type, Application
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Bristol-Myers Squibb Company, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences Inc., Novo Nordisk A/S, Dr. Reddy's Laboratories Ltd., Vir Biotechnology Inc., Alnylam Pharmaceuticals Inc., Indian Immunologicals Limited, Intercept Pharmaceuticals Inc., Viking Therapeutics Inc., Ascletis Pharma Inc., Ochre Bio Limited, Tiziana Life Sciences Ltd., Antios Therapeutics Inc.
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Chronic Liver Diseases Therapeutics Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Chronic Liver Diseases Therapeutics Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Chronic Liver Diseases Therapeutics Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Chronic Liver Diseases Therapeutics Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Increasing Development Of Targeted Liver Therapies

4.2.2 Rising Focus On Disease-Specific Treatment Approaches

4.2.3 Growing Adoption Of Combination Drug Regimens

4.2.4 Expansion Of Non-Invasive Disease Monitoring

4.2.5 Enhanced Emphasis On Slowing Disease Progression

5. Chronic Liver Diseases Therapeutics Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Hepatology Clinics

5.3 Specialty Pharmacies

5.4 Research Institutions

5.5 Retail Pharmacies

6. Chronic Liver Diseases Therapeutics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Chronic Liver Diseases Therapeutics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Chronic Liver Diseases Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Chronic Liver Diseases Therapeutics Market Size, Comparisons And Growth Rate Analysis

7.3. Global Chronic Liver Diseases Therapeutics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Chronic Liver Diseases Therapeutics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Chronic Liver Diseases Therapeutics Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Chronic Liver Diseases Therapeutics Market Segmentation

9.1. Global Chronic Liver Diseases Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Antiviral Drugs, Immunosuppressants Vaccines, Immunoglobulins, Corticosteroids, Targeted Therapy, Chemotherapy

9.2. Global Chronic Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hepatitis, Autoimmune Diseases, Non-Alcoholic Fatty Liver Disease, Cancer, Genetic Disorders

9.3. Global Chronic Liver Diseases Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

9.4. Global Chronic Liver Diseases Therapeutics Market, Sub-Segmentation Of Antiviral Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Nucleoside Or Nucleotide Analogues, Interferons, Direct-Acting Antivirals

9.5. Global Chronic Liver Diseases Therapeutics Market, Sub-Segmentation Of Immunosuppressants Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Calcineurin Inhibitors, mTOR Inhibitors, Purine Synthesis Inhibitors

9.6. Global Chronic Liver Diseases Therapeutics Market, Sub-Segmentation Of Immunoglobulins, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hepatitis B Immune Globulin, Intravenous Immunoglobulin

9.7. Global Chronic Liver Diseases Therapeutics Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Prednisolone, Methylprednisolone, Dexamethasone

9.8. Global Chronic Liver Diseases Therapeutics Market, Sub-Segmentation Of Targeted Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Tyrosine Kinase Inhibitors, Monoclonal Antibodies

9.9. Global Chronic Liver Diseases Therapeutics Market, Sub-Segmentation Of Chemotherapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Systemic Chemotherapy, Transarterial Chemoembolization Agents

10. Chronic Liver Diseases Therapeutics Market Regional And Country Analysis

10.1. Global Chronic Liver Diseases Therapeutics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Chronic Liver Diseases Therapeutics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Chronic Liver Diseases Therapeutics Market

11.1. Asia-Pacific Chronic Liver Diseases Therapeutics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Chronic Liver Diseases Therapeutics Market, Segmentation By Treatment Type, Segmentation By Disease Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Chronic Liver Diseases Therapeutics Market

12.1. China Chronic Liver Diseases Therapeutics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Chronic Liver Diseases Therapeutics Market, Segmentation By Treatment Type, Segmentation By Disease Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Chronic Liver Diseases Therapeutics Market

13.1. India Chronic Liver Diseases Therapeutics Market, Segmentation By Treatment Type, Segmentation By Disease Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Chronic Liver Diseases Therapeutics Market

14.1. Japan Chronic Liver Diseases Therapeutics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Chronic Liver Diseases Therapeutics Market, Segmentation By Treatment Type, Segmentation By Disease Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Chronic Liver Diseases Therapeutics Market

15.1. Australia Chronic Liver Diseases Therapeutics Market, Segmentation By Treatment Type, Segmentation By Disease Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Chronic Liver Diseases Therapeutics Market

16.1. Indonesia Chronic Liver Diseases Therapeutics Market, Segmentation By Treatment Type, Segmentation By Disease Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Chronic Liver Diseases Therapeutics Market

17.1. South Korea Chronic Liver Diseases Therapeutics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Chronic Liver Diseases Therapeutics Market, Segmentation By Treatment Type, Segmentation By Disease Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Chronic Liver Diseases Therapeutics Market

18.1. Taiwan Chronic Liver Diseases Therapeutics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Chronic Liver Diseases Therapeutics Market, Segmentation By Treatment Type, Segmentation By Disease Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Chronic Liver Diseases Therapeutics Market

19.1. South East Asia Chronic Liver Diseases Therapeutics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Chronic Liver Diseases Therapeutics Market, Segmentation By Treatment Type, Segmentation By Disease Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Chronic Liver Diseases Therapeutics Market

20.1. Western Europe Chronic Liver Diseases Therapeutics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Chronic Liver Diseases Therapeutics Market, Segmentation By Treatment Type, Segmentation By Disease Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Chronic Liver Diseases Therapeutics Market

21.1. UK Chronic Liver Diseases Therapeutics Market, Segmentation By Treatment Type, Segmentation By Disease Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Chronic Liver Diseases Therapeutics Market

22.1. Germany Chronic Liver Diseases Therapeutics Market, Segmentation By Treatment Type, Segmentation By Disease Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Chronic Liver Diseases Therapeutics Market

23.1. France Chronic Liver Diseases Therapeutics Market, Segmentation By Treatment Type, Segmentation By Disease Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Chronic Liver Diseases Therapeutics Market

24.1. Italy Chronic Liver Diseases Therapeutics Market, Segmentation By Treatment Type, Segmentation By Disease Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Chronic Liver Diseases Therapeutics Market

25.1. Spain Chronic Liver Diseases Therapeutics Market, Segmentation By Treatment Type, Segmentation By Disease Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Chronic Liver Diseases Therapeutics Market

26.1. Eastern Europe Chronic Liver Diseases Therapeutics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Chronic Liver Diseases Therapeutics Market, Segmentation By Treatment Type, Segmentation By Disease Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Chronic Liver Diseases Therapeutics Market

27.1. Russia Chronic Liver Diseases Therapeutics Market, Segmentation By Treatment Type, Segmentation By Disease Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Chronic Liver Diseases Therapeutics Market

28.1. North America Chronic Liver Diseases Therapeutics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Chronic Liver Diseases Therapeutics Market, Segmentation By Treatment Type, Segmentation By Disease Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Chronic Liver Diseases Therapeutics Market

29.1. USA Chronic Liver Diseases Therapeutics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Chronic Liver Diseases Therapeutics Market, Segmentation By Treatment Type, Segmentation By Disease Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Chronic Liver Diseases Therapeutics Market

30.1. Canada Chronic Liver Diseases Therapeutics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Chronic Liver Diseases Therapeutics Market, Segmentation By Treatment Type, Segmentation By Disease Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Chronic Liver Diseases Therapeutics Market

31.1. South America Chronic Liver Diseases Therapeutics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Chronic Liver Diseases Therapeutics Market, Segmentation By Treatment Type, Segmentation By Disease Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Chronic Liver Diseases Therapeutics Market

32.1. Brazil Chronic Liver Diseases Therapeutics Market, Segmentation By Treatment Type, Segmentation By Disease Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Chronic Liver Diseases Therapeutics Market

33.1. Middle East Chronic Liver Diseases Therapeutics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Chronic Liver Diseases Therapeutics Market, Segmentation By Treatment Type, Segmentation By Disease Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Chronic Liver Diseases Therapeutics Market

34.1. Africa Chronic Liver Diseases Therapeutics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Chronic Liver Diseases Therapeutics Market, Segmentation By Treatment Type, Segmentation By Disease Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Chronic Liver Diseases Therapeutics Market Regulatory and Investment Landscape

36. Chronic Liver Diseases Therapeutics Market Competitive Landscape And Company Profiles

36.1. Chronic Liver Diseases Therapeutics Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Chronic Liver Diseases Therapeutics Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Chronic Liver Diseases Therapeutics Market Company Profiles

36.3.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

37. Chronic Liver Diseases Therapeutics Market Other Major And Innovative Companies

GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences Inc., Novo Nordisk A/S, Dr. Reddy's Laboratories Ltd., Vir Biotechnology Inc., Alnylam Pharmaceuticals Inc., Indian Immunologicals Limited, Intercept Pharmaceuticals Inc., Viking Therapeutics Inc., Ascletis Pharma Inc., Ochre Bio Limited, Tiziana Life Sciences Ltd., Antios Therapeutics Inc.

38. Global Chronic Liver Diseases Therapeutics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Chronic Liver Diseases Therapeutics Market

40. Chronic Liver Diseases Therapeutics Market High Potential Countries, Segments and Strategies

40.1 Chronic Liver Diseases Therapeutics Market In 2030 - Countries Offering Most New Opportunities

40.2 Chronic Liver Diseases Therapeutics Market In 2030 - Segments Offering Most New Opportunities

40.3 Chronic Liver Diseases Therapeutics Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Chronic Liver Diseases Therapeutics Market, Overview Of Key Products - Product Examples
  • Table 2: Global Chronic Liver Diseases Therapeutics Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Chronic Liver Diseases Therapeutics Market, Supply Chain Analysis
  • Table 4: Global Chronic Liver Diseases Therapeutics Market, Major Raw Material Providers
  • Table 5: Global Chronic Liver Diseases Therapeutics Market, Major Resource Providers
  • Table 6: Global Chronic Liver Diseases Therapeutics Market, Major Manufacturers (Suppliers)
  • Table 7: Global Chronic Liver Diseases Therapeutics Market, Major Distributors And Channel Partners
  • Table 8: Global Chronic Liver Diseases Therapeutics Market, Key Technologies & Future Trends
  • Table 9: Global Chronic Liver Diseases Therapeutics Market, Major Trends
  • Table 10: Global Chronic Liver Diseases Therapeutics Market, Major End Users
  • Table 11: Global Chronic Liver Diseases Therapeutics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Chronic Liver Diseases Therapeutics Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Chronic Liver Diseases Therapeutics Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Chronic Liver Diseases Therapeutics Market - TAM, US$ Billion, 2025
  • Table 15: Global Chronic Liver Diseases Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Chronic Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Chronic Liver Diseases Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Chronic Liver Diseases Therapeutics Market, Sub-Segmentation Of Antiviral Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Chronic Liver Diseases Therapeutics Market, Sub-Segmentation Of Immunosuppressants Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Chronic Liver Diseases Therapeutics Market, Sub-Segmentation Of Immunoglobulins, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Chronic Liver Diseases Therapeutics Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Chronic Liver Diseases Therapeutics Market, Sub-Segmentation Of Targeted Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Chronic Liver Diseases Therapeutics Market, Sub-Segmentation Of Chemotherapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Global Chronic Liver Diseases Therapeutics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Global Chronic Liver Diseases Therapeutics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Asia-Pacific, Chronic Liver Diseases Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: Asia-Pacific, Chronic Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: Asia-Pacific, Chronic Liver Diseases Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: China, Chronic Liver Diseases Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: China, Chronic Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: China, Chronic Liver Diseases Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: India, Chronic Liver Diseases Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: India, Chronic Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: India, Chronic Liver Diseases Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Japan, Chronic Liver Diseases Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Japan, Chronic Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Japan, Chronic Liver Diseases Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Australia, Chronic Liver Diseases Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Australia, Chronic Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Australia, Chronic Liver Diseases Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Indonesia, Chronic Liver Diseases Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: Indonesia, Chronic Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: Indonesia, Chronic Liver Diseases Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: South Korea, Chronic Liver Diseases Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: South Korea, Chronic Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: South Korea, Chronic Liver Diseases Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Taiwan, Chronic Liver Diseases Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: Taiwan, Chronic Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: Taiwan, Chronic Liver Diseases Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: South East Asia, Chronic Liver Diseases Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: South East Asia, Chronic Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: South East Asia, Chronic Liver Diseases Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Western Europe, Chronic Liver Diseases Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: Western Europe, Chronic Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: Western Europe, Chronic Liver Diseases Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: UK, Chronic Liver Diseases Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: UK, Chronic Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: UK, Chronic Liver Diseases Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Germany, Chronic Liver Diseases Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: Germany, Chronic Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Germany, Chronic Liver Diseases Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: France, Chronic Liver Diseases Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: France, Chronic Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: France, Chronic Liver Diseases Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Italy, Chronic Liver Diseases Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Italy, Chronic Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Italy, Chronic Liver Diseases Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Spain, Chronic Liver Diseases Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Spain, Chronic Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Spain, Chronic Liver Diseases Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Eastern Europe, Chronic Liver Diseases Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Eastern Europe, Chronic Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Eastern Europe, Chronic Liver Diseases Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Russia, Chronic Liver Diseases Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: Russia, Chronic Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: Russia, Chronic Liver Diseases Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: North America, Chronic Liver Diseases Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: North America, Chronic Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: North America, Chronic Liver Diseases Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: USA, Chronic Liver Diseases Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: USA, Chronic Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: USA, Chronic Liver Diseases Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: Canada, Chronic Liver Diseases Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: Canada, Chronic Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: Canada, Chronic Liver Diseases Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: South America, Chronic Liver Diseases Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: South America, Chronic Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: South America, Chronic Liver Diseases Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Brazil, Chronic Liver Diseases Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Brazil, Chronic Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Brazil, Chronic Liver Diseases Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Middle East, Chronic Liver Diseases Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Middle East, Chronic Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Middle East, Chronic Liver Diseases Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Africa, Chronic Liver Diseases Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Africa, Chronic Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 97: Africa, Chronic Liver Diseases Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 98: Global Chronic Liver Diseases Therapeutics Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 99: Global Chronic Liver Diseases Therapeutics Market - Company Scoring Matrix
  • Table 100: F. Hoffmann-La Roche AG Financial Performance
  • Table 101: Merck & Co. Inc. Financial Performance
  • Table 102: AbbVie Inc. Financial Performance
  • Table 103: Bristol-Myers Squibb Company Financial Performance
  • Table 104: Novartis AG Financial Performance
  • Table 105: Global Chronic Liver Diseases Therapeutics Market, Competitive Benchmarking (In USD Billions)
  • Table 106: Global Chronic Liver Diseases Therapeutics Market, Competitive Dashboard
  • Table 107: Global Chronic Liver Diseases Therapeutics Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 108: Global, Chronic Liver Diseases Therapeutics Market Size Gain ($ Billion), Segmentation By Treatment Type, 2025 – 2030
  • Table 109: Global, Chronic Liver Diseases Therapeutics Market Size Gain ($ Billion), Segmentation By Disease Type, 2025 – 2030
  • Table 110: Global, Chronic Liver Diseases Therapeutics Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

List Of Figures

    Figure 1: Global Chronic Liver Diseases Therapeutics Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Chronic Liver Diseases Therapeutics Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Chronic Liver Diseases Therapeutics Market, Supply Chain Analysis
  • Figure 4: Global Chronic Liver Diseases Therapeutics Market, Major Raw Material Providers
  • Figure 5: Global Chronic Liver Diseases Therapeutics Market, Major Resource Providers
  • Figure 6: Global Chronic Liver Diseases Therapeutics Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Chronic Liver Diseases Therapeutics Market, Major Distributors And Channel Partners
  • Figure 8: Global Chronic Liver Diseases Therapeutics Market, Key Technologies & Future Trends
  • Figure 9: Global Chronic Liver Diseases Therapeutics Market, Major Trends
  • Figure 10: Global Chronic Liver Diseases Therapeutics Market, Major End Users
  • Figure 11: Global Chronic Liver Diseases Therapeutics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Chronic Liver Diseases Therapeutics Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Chronic Liver Diseases Therapeutics Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Chronic Liver Diseases Therapeutics Market - TAM, US$ Billion, 2025
  • Figure 15: Global Chronic Liver Diseases Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Chronic Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Chronic Liver Diseases Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Chronic Liver Diseases Therapeutics Market, Sub-Segmentation Of Antiviral Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Chronic Liver Diseases Therapeutics Market, Sub-Segmentation Of Immunosuppressants Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Chronic Liver Diseases Therapeutics Market, Sub-Segmentation Of Immunoglobulins, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Chronic Liver Diseases Therapeutics Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Chronic Liver Diseases Therapeutics Market, Sub-Segmentation Of Targeted Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Chronic Liver Diseases Therapeutics Market, Sub-Segmentation Of Chemotherapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Global Chronic Liver Diseases Therapeutics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Global Chronic Liver Diseases Therapeutics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Asia-Pacific, Chronic Liver Diseases Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: Asia-Pacific, Chronic Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: Asia-Pacific, Chronic Liver Diseases Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: China, Chronic Liver Diseases Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: China, Chronic Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: China, Chronic Liver Diseases Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: India, Chronic Liver Diseases Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: India, Chronic Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: India, Chronic Liver Diseases Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Japan, Chronic Liver Diseases Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Japan, Chronic Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Japan, Chronic Liver Diseases Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Australia, Chronic Liver Diseases Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Australia, Chronic Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Australia, Chronic Liver Diseases Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Indonesia, Chronic Liver Diseases Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: Indonesia, Chronic Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: Indonesia, Chronic Liver Diseases Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: South Korea, Chronic Liver Diseases Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: South Korea, Chronic Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: South Korea, Chronic Liver Diseases Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Taiwan, Chronic Liver Diseases Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: Taiwan, Chronic Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: Taiwan, Chronic Liver Diseases Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: South East Asia, Chronic Liver Diseases Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: South East Asia, Chronic Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: South East Asia, Chronic Liver Diseases Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Western Europe, Chronic Liver Diseases Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: Western Europe, Chronic Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: Western Europe, Chronic Liver Diseases Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: UK, Chronic Liver Diseases Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: UK, Chronic Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: UK, Chronic Liver Diseases Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Germany, Chronic Liver Diseases Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: Germany, Chronic Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Germany, Chronic Liver Diseases Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: France, Chronic Liver Diseases Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: France, Chronic Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: France, Chronic Liver Diseases Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Italy, Chronic Liver Diseases Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Italy, Chronic Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Italy, Chronic Liver Diseases Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Spain, Chronic Liver Diseases Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Spain, Chronic Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Spain, Chronic Liver Diseases Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Eastern Europe, Chronic Liver Diseases Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Eastern Europe, Chronic Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Eastern Europe, Chronic Liver Diseases Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Russia, Chronic Liver Diseases Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: Russia, Chronic Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: Russia, Chronic Liver Diseases Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: North America, Chronic Liver Diseases Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: North America, Chronic Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: North America, Chronic Liver Diseases Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: USA, Chronic Liver Diseases Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: USA, Chronic Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: USA, Chronic Liver Diseases Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: Canada, Chronic Liver Diseases Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: Canada, Chronic Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: Canada, Chronic Liver Diseases Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: South America, Chronic Liver Diseases Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: South America, Chronic Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: South America, Chronic Liver Diseases Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Brazil, Chronic Liver Diseases Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Brazil, Chronic Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Brazil, Chronic Liver Diseases Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Middle East, Chronic Liver Diseases Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Middle East, Chronic Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Middle East, Chronic Liver Diseases Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Africa, Chronic Liver Diseases Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Africa, Chronic Liver Diseases Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 97: Africa, Chronic Liver Diseases Therapeutics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 98: Global Chronic Liver Diseases Therapeutics Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 99: Global Chronic Liver Diseases Therapeutics Market - Company Scoring Matrix
  • Figure 100: F. Hoffmann-La Roche AG Financial Performance
  • Figure 101: Merck & Co. Inc. Financial Performance
  • Figure 102: AbbVie Inc. Financial Performance
  • Figure 103: Bristol-Myers Squibb Company Financial Performance
  • Figure 104: Novartis AG Financial Performance
  • Figure 105: Global Chronic Liver Diseases Therapeutics Market, Competitive Benchmarking (In USD Billions)
  • Figure 106: Global Chronic Liver Diseases Therapeutics Market, Competitive Dashboard
  • Figure 107: Global Chronic Liver Diseases Therapeutics Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 108: Global, Chronic Liver Diseases Therapeutics Market Size Gain ($ Billion), Segmentation By Treatment Type, 2025 – 2030
  • Figure 109: Global, Chronic Liver Diseases Therapeutics Market Size Gain ($ Billion), Segmentation By Disease Type, 2025 – 2030
  • Figure 110: Global, Chronic Liver Diseases Therapeutics Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

Read More About Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Read More About 2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Read More About Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.4% Projected for Catastrophic Antiphospholipid Syndrome Market From 2025 to 2029

Read More About CAGR of 10.4% Projected for Catastrophic Antiphospholipid Syndrome Market From 2025 to 2029

Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

Read More About Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

Read More About 2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

Future Demand and Leading Companies Shaping the Common Cold Market to 2029

Read More About Future Demand and Leading Companies Shaping the Common Cold Market to 2029

Liver Diseases Therapeutics Market Report 2026 - Global Outlook – By Disease Type (Hepatitis, Non-Alcoholic Fatty Liver Disease, Alcohol-Induced, Liver Cancer ), By Treatment (Antiviral, Chemotherapy, Immunosuppressive A...

Liver Health Supplements Market Report 2026 - Global Outlook – By Product (Vitamin And Minerals, Herbal Supplements, Other Products), By Nature (Organic, Conventional), By Form (Dry, Tablets, Powder, Liquid), By Distribu...

Hepatitis Therapeutics Market Report 2026 - Global Outlook – By Disease Type (Hepatitis A, Hepatitis B, Hepatitis C, Other Disease Types), By Drug Class (Oral Antivirals, Immune Modulators), By Distribution Channel (Hosp...

Fatty Liver Treatment Market Report 2026 - Global Outlook – By Treatment Type (Anti-Viral Drugs, Chemotherapy Drugs, Targeted Therapy, Anti-Fibrotic Drugs), By Disease Type (Hepatitis, Liver Cancer, Non-Alcoholic Fatty L...

Liver Metastases Treatment Market Report 2026 - Global Outlook – By Treatment Type (Chemotherapy, Targeted Therapy, Immunotherapy), By Primary Cancer (Colorectal Cancer, Breast Cancer), By Distribution Channel (Hospital ...

Hepatitis Drugs Market Report 2026 - Global Outlook – By Drug Class (Interferon Alphas, HIV NRTIs, Nucleotide Polymerase Or NS5A Inhibitor Combinations, Hepatitis C Protease Or NS5A Inhibitor Combinations, NS5A Inhibitor...

Hepatocellular Carcinoma Drugs Market Report 2026 - Global Outlook – By Type (Brachytherapy, Chemotherapy), By Drug Class (PD-1/PD-L1 Inhibitors, Tyrosine Kinase Inhibitors), By End User (Hospitals, Clinics, Cancer Rehab...

Alcoholic Hepatitis Treatment Market Report 2026 - Global Outlook – By Treatment Type (Drug Therapy, Supportive And Nutritional Therapy), By Route Of Administration (Oral, Injectable), By Severity Of Disease (Mild Alcoho...

Frequently Asked Questions

The Chronic Liver Diseases Therapeutics market was valued at $15.88 billion in 2025, increased to $17.56 billion in 2026, and is projected to reach $25.99 billion by 2030.

The global Chronic Liver Diseases Therapeutics market is expected to grow at a CAGR of 10.3% from 2026 to 2035 to reach $25.99 billion by 2035.

Some Key Players in the Chronic Liver Diseases Therapeutics market Include, F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Bristol-Myers Squibb Company, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences Inc., Novo Nordisk A/S, Dr. Reddy's Laboratories Ltd., Vir Biotechnology Inc., Alnylam Pharmaceuticals Inc., Indian Immunologicals Limited, Intercept Pharmaceuticals Inc., Viking Therapeutics Inc., Ascletis Pharma Inc., Ochre Bio Limited, Tiziana Life Sciences Ltd., Antios Therapeutics Inc. .

Major trend in this market includes: Advancements In Autologous Macrophage–Based Therapeutic Innovations. For further insights on this market. request a sample here

North America was the largest region in the chronic liver diseases therapeutics market in 2025. The regions covered in the chronic liver diseases therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us